§ Federal grant opportunity · RFA-DK-27-116
The NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC) Genomic Research Centers
National Institutes of Health is accepting applications for The NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC) Genomic Research Centers. The deadline is Rolling / not published and the published award range is Award amount not published.
Key facts
- Funder
- National Institutes of Health
- Application deadline
- Rolling / not published
- Award range
- Award amount not published
- Eligibility
- other, for profit organizations other than small businesses, county governments, independent school districts, state governments, other native american tribal organizations, special district governments, nonprofits non higher education with 501c3, public and state institutions of higher education, public and indian housing authorities, private institutions of higher education, small businesses, city or township governments, federally recognized native american tribal governments
- Geography
- United States
- Focus areas
- Health
- Opportunity number
- RFA-DK-27-116
Program overview
The National Institute of Diabetes and Digestive Diseases and Nutrition (NIDDK) seeks to advance its mission by continuing the NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC). The IBDGC has led collaborative efforts resulting in the identification of >300 genetic risk loci for different IBD subtypes across patient populations and characterization of underlying biological mechanisms. Despite advances in biological understanding and the development of a range of biologic therapies, IBD remains a chronic, severe and heterogenous disease with no cure requiring multiple interventions over the life course. Diagnostic biomarkers and accurate predictors of critical outcomes including disease remission, recurrence, and response to specific therapies are lacking. The IBDGC will leverage patient cohorts, biospecimens and advances in data science to characterize the interactions of genetic, clinical and environmental factors in disease development and progression, and to develop new predictors of disease outcomes, with the goal of improving medical management and advancing precision medicine for IBD patients. The IBDGC may include up to 7 Genomic Research Centers with varying research emphases, which will serve as sites for participant enrollment, molecular analysis of biospecimens and bioinformatics and computational analyses.
How to apply
- Confirm your organization meets the eligibility criteria above.
- Read the full funding opportunity announcement from National Institutes of Health.
- Draft your narrative against the funder's stated priorities and review criteria.
- Submit before Rolling / not published, allowing time for registration and validation.
Related grant opportunities
- HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional)
- NIJ FY 2026 Research on Gender Dysphoria and Violent Crime
- Cellular Senescence Network (SenNet): Discovery, Validation Centers (UM1 Clinical Trials Not Allowed)
- Cellular Senescence Network (SenNet): SenNet Technology Projects (SenTecs) (UG3/UH3 Clinical Trial Not Allowed)
- Cellular Senescence Network (SenNet): SenNet Data Coordination and Integration Center (SenNet DCIC) (UM1 Clinical Trials Not Allowed)
Find every grant your organization qualifies for
Mavenly scores this opportunity against your mission, geography, and funding history — then drafts the proposal with you and tracks the deadline through submission and reporting.